WomenHIV2025_Int
Meeting category
Date(s)
4 Apr 2025 - 5 Apr 2025
Location
Barcelona, Spain
Meeting type
Hybrid Meeting

15th International Workshop on Women & HIV 2025

General
What's New
  • The International Workshop on Women & HIV 2025, Barcelona, Spain 04/04/2025 - 05/04/2025, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10.5 European CME credits (ECMEC®s).

  • Women & HIV will take place at the Novotel Barcelona City in Barcelona, Spain, from 4-5 April 2025!

  • To stay updated on the relevant developments, make sure you are signed up for our newsletter

About this Program

The 15th International Workshop on Women & HIV will take place in a hybrid format from 4-5 April 2025 in Barcelona, Spain.

The International Workshop on Women & HIV has now completed its 14th year and continues to evolve. It is an outstanding opportunity for healthcare providers, researchers, government, industry, and community representatives to discuss, debate, and further their knowledge on the issues related to HIV and women.

The format of the workshop enables attendees to learn from world-leading HIV experts and discuss the issues, gaps, and opportunities for further learning and research. Many of the attendees continue to participate each year and have formed valuable relationships and partnerships that have led to collaborative projects.

The enthusiasm and dedication of the participants is palpable throughout the workshop. The debates and roundtables are an important vehicle to discuss the issues and challenge dogmas.

Over the years, the number and quality of submitted abstracts have continued to improve. The workshop also provides a forum for early-career investigators to present their work and to personally meet with experts they view as mentors and inspirations for their work. The workshop considers both local and global issues and the information learnt in one setting is often translated into another.

We encourage you to consider joining us in 2025! 

On behalf of the Organizing Committee

Workshop Chair
Local Chairs
General Information 
Uniques Features
- Two-day hybrid meeting
- Invited lectures from international experts
- Interactive roundtable sessions
- Ample time for discussion
Who Should Attend?
- HIV clinicians
- Researchers
- OBGYNs
- Government and NGO representatives
- Industry representatives
- Community advocates
- Pharmacists
- Medical Students
- Other healthcare providers involved in daily care of women living with HIV
Meeting Objectives
This meeting aims to:

- Facilitate an unbiased and scientific knowledge exchange regarding HIV & Women, and encourage early-career investigators to actively partake in the workshop;

- Summarize and promote the current state of the science regarding HIV & Women, and its successful translation and dissemination; and

- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers and women to improve knowledge sharing, with the end goal of improving the quality of life of women living with HIV.
Practical Information 
Venue
The workshop will take place in the Novotel Barcelona City.

The address is:
Novotel Barcelona City
Avenida Diagonal,
Carrer de la Ciutat de Granada,
201, Entrada Por,
08018 Barcelona, Spain

Distance from Josep Tarradellas Barcelona-El Prat Airport (BCN): 17 km
Badges
All participants are requested to wear the badge at all times during the conference to ensure admission to the meeting.
Certificate of Attendance
A certificate of attendance will be sent to participants after they successfully complete the program and post-meeting survey.
Language
The official language of the workshop is English
Translation will not be provided.
Enduring Materials
Enduring materials will be available shortly after the conclusion of the workshop.
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.

Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Registration
Please note that payment by credit card is required to be able to register for the workshop. Please contact the conference secretariat if this is not possible for you.
Registration is open!
Fees and Conditions

Regular Delegates-
In-Person

Regular Delegates-
Virtual

Industry* - In-Person

Industry* - Virtual

Early Fee (payment on/before 11 September 2024) 

€495.00

€395.00

€695.00

€595.00

Regular Fee (payment on/before 4 February 2025)

€695.00

€595.00

€895.00

€795.00

Late Fee (payment from 5 February 2025) 

€795.00

€695.00

€995.00

€895.00

Discounts
Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITH accepted abstract 50% Off Early Fee
Early-Career Investigators / Academia from Resource-Limited Settings (RLS)* WITHOUT accepted abstract 50% Off Current Regular Fee
NGO Representatives / Government Representatives (i.e. MOH, NIH, NIAID, etc.) / Advocates 50% Off Current Regular Fee
Members of Endorsers   25% Off Current Regular Fee

 Sponsors 

Contact Secretariat 

*Countries included in the low-income and middle-income economies list of the World Bank Classification

Important
  • We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.

  • Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.

Registration Fee Includes
For Onsite Attendees:

- Access to all scientific sessions, including poster area

- Workshop pack, including abstract book and program

- Refreshments during the coffee breaks

- Buffet lunch on meeting days

For Virtual Attendees Only:

- Access to all scientific sessions

- Digital workshop pack, including the program book

IMPORTANT:

- No day rate is available

- Payment can only be made by credit card.

- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
Group Registration
For registration of groups larger than 5 participants, please contact the workshop secretariat to use the Group Registration Portal.
Early-Career Investigators / Academia from Resource-limited Settings (RLS)
We are pleased to offer 50% discount on the Early Fee to early-career investigators and academia from low-income and lower-middle-income countries with an accepted abstract, and a 50% discount on the current registration fee without an accepted abstract.

IMPORTANT: Registration fees waivers are offered to the presenting author only.
To be eligible as an early-career investigator, you should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
Sponsored Attendee
If you are invited by a pharmaceutical or diagnostic company, or if your registration is organized by a travel agency, please do not register online. The sponsoring company will be asked to register you via the conference secretariat.
Payment
By credit card only: online or by written authorization (see online registration).
Cancellation Policy
In case of cancellation, the following refunds are applicable:

- Cancellation before/on 4 March 2025: 50% refund (minus an administration fee of €40)

- Cancellation after 4 March 2025: Unfortunately, no refund will be given

If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 28 March 2025. A statement (email/letter) of cancellation must be sent to Virology Education.
Liability and Insurance
By registering for the conference, participants agree that the organizers do not accept responsibility for medical, travel, or personal insurance. Participants are advised to take out their own insurance policies.
Media Registration
In order to register as a media participant for the Conference, the conference secretariat needs to receive:

1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop

A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.

We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.

Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2025 embargo policy.
Disclaimer
This workshop is intended for educational purposes only and aims to offer participants the opportunity to share information. The organizing secretariat of this workshop, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this workshop. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the workshop. In case of cancellation of the meeting due to unforeseen circumstances, Virology Education cannot be held responsible for expenses made for travel, accommodation, visa applications, etc.
Program

The below times are set in Central European Summer Time (CEST). Please, use this tool to convert the timing into your time zone.

Friday, 4 April 2025
Opening & Welcome - 08:30
08:30
Opening & Welcome
Session 1: HIV Epidemic in Women: Where Do We Stand? -
08:55
Global and European Epidemiology & Current Trends in Transmission Routes
Barbara Bartmeyer, DVM PhD
HIV/AIDS, STI Unit, Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany
09:15
#1 Conceptualizing Climate-Informed HIV Prevention: Associations between Extreme Weather Events and Resource Insecurities with HIV Vulnerabilities among Climate-Affected Adolescent Girls and Young Women in Nairobi and Kisumu, Kenya
Carmen Logie
Canada
09:30
#2 Five-Year Trends in Characteristics and Care of Women Diagnosed with HIV during Pregnancy in England, 2018 to 2022
Rebecca Sconza
United Kingdom
09:45
Q&A
10:05
Coffee Break
Session 2: Debate - STATIN Preventive Therapy to Reduce Cardiovascular Risks in Women Living with HIV -
Moderator:
Catherine Hankins, MD, PhD, FRCPC, CM
McGill University, Canada
10:35
Opening Words
Catherine Hankins, MD, PhD, FRCPC, CM
McGill University, Canada
10:45
Voting
10:50
Healthcare Provider: For the Proposition
Carlos Malvestutto, MD, MPH, FIDSA
The Ohio State University Medical Center, United States
10:57
Healthcare Provider: Against the Proposition
Esteban Martínez, MD, PhD
Hospital Clínic & University of Barcelona, Spain
11:04
Community Representative: For the Proposition
Susan Cole, FRSA
Global Network of People with HIV, United Kingdom
11:11
Community Representative: Against the Proposition
Magdalena Ankiersztejn-Bartczak, PhD
Foundation for Social Education, Poland
11:18
Discussion with the Audience
11:25
Rebuttal
11:29
Voting
11:34
Results & Closing
Industry-Supported Symposium - 11:40
11:40
Industry-Supported Symposium 1
12:25
Lunch Break
Session 3: Pregnancy & Breastfeeding -
13:25
Update on The Guidelines for ART and Breastfeeding
Laura Byrne, MBChB, PhD
St George's University Hospitals NHS Foundation Trust, United Kingdom
13:45
#3 Breastfeeding in Women Living with HIV: A South East London Clinic’s 9 Years’ Experience
Emily Mabonga
United Kingdom
14:00
#4 Tele-Lactation as a Tool for Equitable HIV Care: An Examination of Lactation Consultant HIV Knowledge, HIV-Related Stigma, Tele-Lactation Experience, and Willingness to Support Breastfeeding/Chestfeeding People with HIV in North America
Emily Anne Barr
United States
14:15
#5 The Well Project Survey Reveals Dramatic Shift in Provider Support of Breast/Chestfeeding After 2023 HIV Guideline Updates
Ciarra Covin
United States
14:30
#6 Unravelling the Pharmacokinetic Mechanism Explaining Lower Bictegravir Exposure during Pregnancy
Lena Christina Wendy Van Der Wekken-Pas
The Netherlands
14:45
Panel Discussion: Including Women with Lived Experience
15:15
Coffee Break
Session 4: New Landscape of PrEP -
15:45
PrEP Overview (incl. Recent Data on Lenacapavir Trial)
Linda-Gail Bekker, MBChB, DTMH, DCH, FCP(SA), PhD
Desmond Tutu Health Foundation / University of Cape Town (UCT), South Africa
16:05
PrEP Implementation During the Refugee Crisis
Anna Koval, MD
University Medical Center Hamburg-Eppendorf, Germany
16:25
#7 HIV Pre-exposure Prophylaxis Uptake and Adherence Amongst Adolescent Girls and Young Women in the DREAMS Urban Model Program in Wakiso, Uganda
Molly Nagawa
Uganda
16:40
#8 A Game Changer: Acceptability of Long-Acting Injectable PrEP (Cabotegravir) Among Female Sex Workers and Men Who Have Sex with Men in Nakonde District, Zambia
Lubinda Chingumbe
Zambia
16:55
Q&A
17:15
Welcome Reception & Guided Poster Tours (4 Parallel Sessions)
Guided Poster Tour 1: HPV, Cervical Cancer and Screening
Moderator:
.
#17 Enhancing Cervical Cancer Screening Coverage in Selected Primary Health Care Clinics in South Africa using Lean Thinking: The CerviScreen Programme
Logandran Naidoo, South Africa
#18 Systematic Review and Meta-Analysis of Human Papilloma Virus Prevalence and Genotype Disparity among HIV Infected Women in Africa
Amare Yirga Wondu, Hungary
#19 Strengthening HIV and Cervical Cancer Prevention through Community Engagement in Tanzania: Community-Led Monitoring (CLM) as Mechanism to Understand Gender Inequality and Address Barriers That Women Face in Accessing Comprehensive Healthcare
Ángela León Cáceres, Ecuador
#20 Integration of Cervical Cancer Screening and HIV Care and Treatment at Mama Lucy Kibaki Hospital
Alatinah Ngaira, Kenya
#21 Type-specific Human Papillomavirus and its Association with Human T Lymphotropic Virus-1 among Women Accessing HIV Care at Kenyatta National Hospital
James Mburu Kangethe, Kenya
Guided Poster Tour 2: ART
Moderator:
.
#22 Associations between Maternal Hormones and Birth Anthropometrics Differ between ARV Classes
Lena Serghides, Canada
#23 Women With HIV Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF): 24-Month Effectiveness, Safety, and Patient-Reported Outcomes (PROs) From the Prospective Observational BICSTaR Study
Hila Elinav, Israel
#24 Perinatal and Early Infant Outcomes after Bictegravir Exposure in Pregnancy: A Canadian Surveillance Study
Jeffrey Man Hay Wong, Canada
#25 The RISE Infant Feeding Framework: A Conceptual Multi-Level Approach to Understanding Infant Feeding Among People with HIV in Higher-Income Countries
Emily Anne Barr, United States
#26 Doravirine in Breastmilk of Healthy, Lactating, Hiv-Negative Women after a Single Dose of 100mg
Lena Christina Wendy Van Der Wekken-Pas, The Netherlands
#27 Perinatal and Neonatal Outcomes after 1st vs. 2nd Generation INSTI Use in Pregnancy
Rosa Balleny, Canada
Guided Poster Tour 3: Challenges
Moderator:
.
#28 Navigating Futures: The Vital Role of Integrating a Comprehensive Family Planning Approach for Adolescent Girls and Young Women on the DREAMS Initiative in Kapiri Mposhi District, Central Zambia
Kangwa Kasonde, Zambia
#29 Is Housing Instability Linked to Poor Health Outcomes in Women Living in the US?
Maeve Brin, United States
#30 Latina and Black Woman HIV and STI Disparities Can Not Be Dismissed. A 10 Year Analysis of the Situation in Travis County, Texas, 2013-2023
Flor Hernandez Ayala, United States
#31 An Updated Analysis of the Percentage of Specimens with a Count <100 and ≥100-≤200 Cells/µL for Adolescent Girls and Young Women in South Africa for 2023
Naseem Cassim, South Africa
#32 Unveiling an Overlooked Population: Climacteric Symptom Prevalence in Women with HIV in Mexico City
Angelina Silva-Casarrubias, Mexico
#33 Current Practice of Healthcare Professionals When Screening for and Managing Low Bone Mineral Density in Women Living with HIV in the UK
Hajra Okhai, United Kingdom
Guided Poster Tour 4: Mental Health
Moderator:
.
#34 The Intersection of Viral Load Categories and Depression Among Women Living with HIV: A Focus on Mental Health Disparities
Jonathan Lukusa Tshimwanga, Namibia
#35 Suicidality and Crisis: A Longitudinal Exploration of Suicidality in Adolescent Mothers Living with and Affected by HIV in South Africa
Kathryn Steventon Roberts, United Kingdom
#36 Managing Menopause in HIV: A Cross-Sectional Study on the Awareness and Interventions of Healthcare Practitioners in a Nigerian Teaching Hospital
Amarachukwu Emmanuella Ugwu, Nigeria
#37 Enhancing Mental Health Screening for Adolescent Girls and Young Women Living with HIV: A Continuous Quality Improvement Approach in Wakiso District, Uganda
Senyonjo Joseph, Uganda
#38 HIV Index Testing, Intimate Partner Violence, and Outcomes Among Females Enrolled Into Anti-Retroviral Therapy
Ikenna Nwakamma, Nigeria
18:15
End of Day 1
Saturday, 5 April
Day 2 Opening - 08:30
08:30
Day 2 Opening
Session 5: HIV Across Lifespan -
08:40
Co-infections & Integrated Care: HPV/Cervical Cancer
Boris Revollo Barriga, MD, PhD
University Hospital Germans Trias, Barcelona, Spain
09:00
Romanian Women Cohort – Study Findings on Women Infected either Vertically or after Birth
Mariana Mărdărescu, MD, PhD
Institute for Infectious Disease Matei Bals, Romania
09:20
#9 Concordance Between ASCVD and PREVENT Cardiovascular Risk Models in Women Living With and Without HIV
Tetiana Povshedna
Canada
09:35
#10 Non-HIV Chronic/Latent Viral Infections Are Associated with Markers of Inflammation in Males but Not Females Living with HIV and Not Living with HIV
Renying Cai
Canada
09:50
#11 Sleep Quality among Women Living with HIV by Reproductive Stage in the United States-Based Hope Study
Rusul Al-Ani
United States
10:05
#12 History of Abnormal Ovarian Function Not Associated with Fibrosis-4 Index among Women Living with or without HIV in British Columbia, Canada
Monika M Kowatsch
Canada
10:20
Q&A
10:40
Coffee Break
Session 6: Beyond Undetectable -
11:10
Managing Non-Communicable Diseases in Women Aging with HIV: NASH
Maria Luisa Montes Ramirez, MD, PhD
HIV Unit, Internal Medicine Department, La Paz University Hospital, IdiPAZ, CIBERINFEC, Madrid, Spain
11:30
Managing Non-Communicable Diseases in Women Aging with HIV: Metabolic syndrome
Alan Winston, MBChB, FRCP, MD
Imperial College, United Kingdom
11:50
#13 Beyond Pills: A Holistic Approach to Supporting Priority Female Populations Living with HIV - Lessons from the Operation Triple Zero (OTZ) Youth Kilifi Chapter
Mhamed Ali Hassan
Kenya
12:05
#14 A Novel Approach to Weight Loss: Bringing SatPro into the HIV Clinic
Eleanor Hamlyn
United Kingdom
12:20
Q&A
12:40
Lunch Break
Symposium II - 13:40
13:40
EATG: Inclusion of Women and Transgender People in Clinical Trials: Advancing Equity in Research
Session 7: Long-Acting Antiretrovirals for Women -
14:40
Long-Acting Drugs for HIV Treatment in Women
Claudia Cortes, MD
University of Chile, Chile
15:00
Real-world data: Challenges on implementation of LA-ART in EU // Which Women Benefit the Most
Ana Gonzalez-Cordón
Clinic Hospital Barcelona, Spain
15:20
#15 Clinical Outcomes among Women Receiving CAB+RPV LA in the OPERA Cohort: Subgroup Differences Based on Race, BMI, and Age
Jessica Altamirano
United States
15:35
#16 Real-World Efficacy and Tolerability of Long-Acting Cabotegravir/Rilpivirine in Older Woman with Polypharmacy and Comorbidities
María Jesús Pérez Elías
Spain
15:50
Discussion: What Does Future Bring? What Are the Priorities For Women?
16:10
Closing Remarks
16:15
End of Workshop
Abstracts

Abstract Submission is closed. 

Abstract Submission Deadline was Friday, 17 January 2025 at 23:59 CET

Abstracts

Abstract Submission is closed.

  • Women & HIV 2025 accepts new original data as well as encored abstracts. All abstracts must focus on Women & HIV and contain up-to-date information at the time of the conference. 
  • Early-career professionals and academia from Resource-Limited Settings with an accepted abstract will be offered a 50% discount on the Early Fee. The requirements for the application are specified here.
  • Abstract submitters are strongly encouraged to use person-first language in their abstracts. View the video tutorial and guidelines here

  • Abstract presenters are expected to attend the workshop in-person to present their abstract.

    Please contact the workshop secretariat if this is not possible.

Categories for Abstract Submission
For purposes of review and programming, abstracts are divided into topical categories. The selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category.

1. Epidemiology of HIV and STIs in Women
2. Strategies Towards the End of AIDS
3. HIV Prevention in Women (Including PrEP and U=U)
4. Diagnosis, Treatment, and Models of Care of HIV Infection for Women
5. Contraception
6. Pregnancy and Vertical Transmission
7. Breastfeeding
8. ART Choices and Toxicity for Women
9. Co-Morbidities and Aging in Women Living With HIV
10. Priority Female Populations: Adolescents, Transgender Women, Sex Workers, People Who Inject Drugs, People Living Within Closed Systems, and other Incarcerated Women (UNAIDS Guidelines)
11. Addressing Challenges Faced by Women Living with HIV
12. Emerging Infections
13. Other Research Relevant to Women and HIV
General Guidelines
Abstracts should contain the following four components:

- Background: A concise statement of the issue under investigation or a hypothesis;

- Material and Methods: The experimental methods used (including the statistical analyses employed);

- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);

- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.

Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.

We encourage you to use person-first language in your abstract(s). View our guidelines here: https://academicmedicaleducation.com/person-first-language
Abstract Submission
Authors can submit their abstracts electronically until Friday, 17 January 2025. You will be redirected to the submission website. Please follow the step-by-step directions to upload the abstract. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.
Poster Presentation Instructions
Note: For hybrid events, poster presenters are expected to attend onsite.
Posters need to meet the following dimensions: A0 size (approx. 33" x 44") in portrait format.
Please display the number of your poster in the upper right corner of your poster.
In addition, you are welcome to make a short recording (max. 2 min) of your presentation with a few slides using PowerPoint. You can record this video directly from PowerPoint.
Your poster and the short video will be available on our website after the workshop days.
Once onsite:
Poster presenters are requested to stand near their posters during the poster session.
We advise you to prepare hand-outs of your poster on Letter or A4 format.
Please hang your posters as early as possible. All posters must be displayed from the opening session to the closure of the meeting.
Pushpins and/or velcro will be provided.
Terms and Conditions
By submitting an abstract to a meeting organized by Virology Education BV (VE), the abstract submitter hereby agrees to the terms and conditions.

The terms and conditions can be viewed here: https://academicmedicaleducation.com/abstract-submission-terms-and-conditions
Committees
Organizing Committee
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Committee

The members of the Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Karoline Aebi-Popp, PD, MD, MSc, University Hospital Bern, Switzerland
  • Sergii Antoniak, MD, Gromashevsky Institute of Epidemiology and Infectious Diseases, National Academy of Medical Sciences of Ukraine, Ukraine
  • Dawn Averitt, The Well Project/WRI, United States
  • Olga Belyaeva, Eurasian Network of People who Use Drugs (ENPUD), Ukraine
  • Marina Bobkova, MD, PhD, Gamaleya Center for Epidemiology and Microbiology, Russian Ministry of Health, Russia                     
  • Claudia Cortes, MD, University of Chile, Chile
  • Dazon Dixon Diallo, MPH, Sister Love, United States
  • Mirjam-Colette Kempf, MD, MPH, University of Alabama at Birmingham, United States
  • Justyna Kowalska, MD, PhD, Hospital for Infectious Diseases, Poland
  • Allen Kyendikuwa, BA, Uganda Youth Coalition on Adolescent SRHR and HIV (CYSRA), Uganda
  • Mona Loutfy, MD, FRCPC, MPH, Women's College Research Institute (Univ. Toronto), Canada
  • Mariana Mardarescu, MD, PhD, National Institute for Infectious Diseases "Prof. Dr. Matei Bals", Romania
  • Catia Marzolini, PharmD, PhD, University Hospital Basel, Switzerland
  • Deborah Money, MD, FRCSC, University of British Columbia, Canada
  • Teresia Otieno, ATHENA Network, United States
  • Lena Serghides, PhD, University Health Network, Canada
  • William R. Short, MD, MPH, FIDSA, University of Pennsylvania, United States
  • Shema Tariq, PhD, FRCP, University College London, United Kingdom
  • Patricia Vasquez, MD, Hospital San Juan de Dios, Chile
  • Marta Vasylyev, MD, Astar Medical Center, Ukraine
  • Markella Zanni, MD, MGH/Harvard Medical School, United States
Scholarships
Scholarships
The Scholarship Application Portal is closed
Scholarship Application Deadline: 24 January 2025

Virology Education (VE), with support from the industry, is offering scholarships to attend the International Workshop on Women & HIV 2025 from 4-5 April 2025 in Barcelona, Spain. The scholarship covers registration and/or travel, and accommodation. 

The scholarships are supported by industry. These companies will have no control, influence, or involvement in selection of any attendees.

Virology Education is proud to support participation from professionals from underrepresented communities. We strongly recognize the value of conducting our programs with a diverse and inclusive representation of the scientific and medical global community, welcoming a range of backgrounds, experiences, and opinions and embracing the benefits that these differences bring. This diversity and equity are essential to our mission of advancing clinical care and scientific research worldwide.

Read our Code of Conduct

What does the Scholarship Cover?
  • Registration Scholarship: 

  • Registration only
  • Partial Scholarship:

  • Registration
  • Accommodation
  • Full Scholarship:

  • Registration
  • Accommodation
  • Travel
What is Expected from the Scholarship Recipents?

All scholarship awardees are required to attend the full meeting. Awardees must sign in at the beginning of each meeting day and sign off at the end of each day as requested by the Conference Organizer. At the close of the Workshop, awardees must have completed the daily and overall workshop evaluations.

Recipient will provide post-meeting feedback and a summary about his/her workshop experience within one month after the end of the workshop. The feedback questionnaire will be an online survey with the recipient providing feedback on their experience at the workshop, scholarship procedure, and how they will implement the knowledge acquired at the meeting in their daily practice. The questionnaire will be sent to each recipient by email within one week after the conclusion of the workshop.

Eligibility

Applicants must:

  • Be proficient in english to interact with faculty and fellow attendees
  • Be actively involved in the field of HIV & Women
  • Be able to show benefits to their patients / research / community from attending the meeting
  • Be willing and able to share information learned at the meeting with a larger community
  • Be eligible to obtain a visa for travel. Declare that she/he is able and willing to fund all other costs beyond the scholarship that are involved in attending the workshop, e.g. all other hotel, travel and subsistence expenses NOT covered by the scholarship.
  • Declare to take out her/his own insurance policies (for travel, liability, illness and/or other necessary insurances in relation to her/his participation to the conference).
  • Workshop organizer will automatically decline all scholarship applications that do not conform to the eligibility terms
Application Procedure

The scholarship applications must be submitted online through our Scholarship Application Portal. The applicant will be asked to submit a motivational letter (min. 100 words) describing how their patients/research/community will benefit from the knowledge gained at these meetings, and their knowledge dissemination strategy, a CV, and a letter of recommendation (optional).

  • All applications will be acknowledged upon receipt.
  • All applications will be reviewed by an independent Scholarship Review Committee
  • Successful applicants will be sent a scholarship agreement.
  • After receipt of the signed scholarship agreement, successful applicants will receive instructions for travel arrangements.
  • All applicants will receive notification of the application status no later than 1 month prior to the meeting they are planning to attend.
Selection Criteria
  • Professional background
  • Quality of the abstract (if accepted)
  • Country of residence
  • Recommendation by your supervisor
  • Demonstrable benefits to patients / research / community by the knowledge to be gained at this meeting
  • Strategy of knowledge dissemination
  • Early-Career Investigator
Important
  • Incomplete applications will not be considered. Conference Organizer cannot be held responsible for any incorrect information that is submitted through the scholarship application portal.
  • All travel arrangements will be made by Conference Organizer in collaboration with their preferred business travel partner. Conference Organizer cannot reimburse any travel costs made by participants themselves.
  • Retrospective applications will not be considered.
  • Scholarship recipients must attend the entire conferences.
  • Scholarship recipients are committed to attend the meetings in person. If they fail to do so, they will be charged the full amount of the travel and accommodation costs incurred and will be excluded from applications for future scholarships of Conference Organizer.
  • Scholarships are non-transferrable.
  • Conference Organizer cannot guarantee awarding the scholarship to prospective scholarship recipients until the confirmation of available funds. In the event that sufficient funding for the scholarship is not available, Conference Organizer will not be liable for any expenses or damages incurred by the prospective scholarship recipient with regards to the scholarship application and/or preparation for the meeting.
  • Applications will be considered until the exhaustion of funds.
  • Scholarship recipients will be responsible for all other costs associated with conference attendance.
  • Conference Organizer will not be liable for any injury, death, damage, loss, delay, cost, expense, or inconvenience, causes of action claims and suits for property damage, theft of property or personal injury (including death) arising in connection with the scholarship and participation in the Conference.
  • Conference Organizer reserves the right to make the final decision regarding all applications, which cannot be disputed.
Support
Silver Level
Scholarship Supporter
Support Our Initiative

Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives involved in the International Workshop on Women & HIV 2025.
 
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
 
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Lara da Silva Miguel at Lara@amededu.com.
 
Benefits of Support 
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.

  • Symposium opportunities
  • Non-commercial interviews with company representatives
  • Verbal acknowledgment during the program 
  • Discounted and complimentary registrations for your representatives
  • Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
  • Company acknowledgment on printed meeting materials including but not limited to banners and the program book
  • Digital and printed advertising opportunities 
  • Social media shout-outs
  • Logo on the conference bag 

 
*Subject to the support level

Endorsers
Previous Editions
Accreditation
Accreditation Statement
EACCME logo_2024

The International Workshop on Women & HIV 2025, Barcelona, Spain 04/04/2025 - 05/04/2025 , has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 10.5 European CME credits (ECMEC®s).
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications .

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Language